Bruker (BRKR) Tops Q3 EPS by 12c

Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.32, $0.12 better than the analyst estimate of $0.20. Revenue for the quarter came in at $393.9 million versus the consensus estimate of $394.14 million.

GUIDANCE:

Bruker sees FY2016 EPS of $1.07-$1.11, versus the consensus of $1.00.

• For the year 2016, the Company now expects reported revenue to decline approximately 1% from 2015.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c